Taiko Pharmaceutical Co Ltd is a pharmaceutical company that manufactures and sells gastrointestinal pharmaceuticals and general use pharmaceutical products.

Consolidated Financial Results For The Third Quarter Of The Fiscal Year Ending December 31, 2025 (Under Japanese Gaap)

Consolidated Financial Results For The Third Quarter Of The Fiscal Year Ending December 31, 2025 (Fy2025)

Notice Concerning Revisions To The Full-Year Consolidated Earnings Forecast

Notice Regarding The Formulation Of The Medium-Term Management Plan (Fy2026-2028)

The Completion Of Liquidation Of An Overseas Consolidated Subsidiary (Recording Of Extraordinary Profit) And Revision Of Consolidated Earnings Forecast

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00